Institutional Investors Facing Difficult Challenge as Passive Investing, Unbundling, and Cost Pressures Threaten Their Very Existence According To TABB Group’s Latest Research - US Institutional Equity Trading 2017: In the Eye of the Storm
April 17, 2017 10:30 ET
|
TABB Group
NEW YORK and LONDON, April 17, 2017 (GLOBE NEWSWIRE) -- The reallocation of assets from active, fundamentally-based investment strategies to passive/ETF index-based products has the industry on...
XOMA Reports Second Quarter 2016 Achievements and Financial Results
August 03, 2016 16:01 ET
|
XOMA Corporation
BERKELEY, Calif., Aug. 03, 2016 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq:XOMA), a leader in the discovery and development of therapeutic antibodies, today announced recent achievements and...
XOMA Receives Orphan Drug Designation in the European Union for XOMA 358 for Treatment of Congenital Hyperinsulinism
July 20, 2016 09:00 ET
|
XOMA Corporation
XOMA 358 previously secured Orphan Drug Designation from the FDA for the treatment of Congenital Hyperinsulinism (CHI)Phase 2 clinical studies currently enrolling patients with CHI in the United...
Apigee Announces New Open Banking Solution for PSD2
May 19, 2016 03:00 ET
|
Apigee
LONDON, May 19, 2016 (GLOBE NEWSWIRE) -- OPEN BANKING & PSD2 SUMMIT — Apigee® (NASDAQ:APIC), developer of a leading API platform, today announced Apigee Open Banking APIx, a new software...
WebMoney Gets a European License and is Expanding Its Presence in the European Union
November 17, 2015 05:00 ET
|
WebMoney
LONDON, Nov. 17, 2015 (GLOBE NEWSWIRE) -- The FCA (Financial Conduct Authority) license granted to WebMoney Europe Ltd with head offices in Cambridge, United Kingdom has secured the company's status...
Hemispherx Biopharma Europe N.V./S.A.: Orphan Medicine Designation and European Medicines Agency Public Opinion Summary Published by EMA Regarding Ampligen/Rintatolimod for Ebola Virus Disease (EVD)
May 26, 2015 12:46 ET
|
AIM ImmunoTech Inc.
PHILADELPHIA, May 26, 2015 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE MKT:HEB) (the "Company" or "Hemispherx") announces that the European Medicines Agency (EMA) has published on May 22,...
HSH.com Weekly Mortgage Rates Radar: Fixed Mortgage Rates Jump Back to December Levels
May 13, 2015 05:10 ET
|
QuinStreet
FOSTER CITY, Calif., May 13, 2015 (GLOBE NEWSWIRE) -- Rates on the most popular types of mortgages climbed again this week, according to HSH.com's Weekly Mortgage Rates Radar. The average rate for...
Hemispherx Biopharma Europe N.V./S.A. Receives Orphan Medicine Designation by the European Medicines Agency for Ampligen to Treat Patients With Ebola Virus Disease (EVD)
May 11, 2015 08:30 ET
|
AIM ImmunoTech Inc.
PHILADELPHIA, May 11, 2015 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE MKT:HEB) (the "Company" or "Hemispherx") announces that its European subsidiary, Hemispherx Biopharma Europe N.V./S.A.,...
U.S. Senator Elizabeth Warren, FDIC Vice Chairman Thomas M. Hoenig, St. Louis Fed President James Bullard, ECB Vice President Vitor Constancio, and Other Leading Economists and Policymakers to attend Levy Economics Institute's 24th Annual Hyman P. Minsky Conference, in Washington, D.C., April 15-16
April 07, 2015 09:54 ET
|
Bard College
WASHINGTON, April 7, 2015 (GLOBE NEWSWIRE) -- From April 15 to 16, the Levy Economics Institute of Bard College will gather top policymakers, economists, and analysts at the 24th Annual Hyman P....
Top U.S. and European Economic Leaders to Discuss Dodd-Frank Reforms, Monetary Policy, and the Sustainability of the U.S. Economic Recovery at the Levy Economics Institute's 24th Annual Hyman P. Minsky Conference, in Washington, D.C., April 15-16
March 18, 2015 13:27 ET
|
Bard College
WASHINGTON, March 18, 2015 (GLOBE NEWSWIRE) -- From April 15 to 16, the Levy Economics Institute of Bard College will gather top policymakers, economists, and analysts at the 24th Annual Hyman P....